{"id":2822,"date":"2021-11-30T10:00:00","date_gmt":"2021-11-30T09:00:00","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2822"},"modified":"2025-10-03T10:55:18","modified_gmt":"2025-10-03T08:55:18","slug":"management","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/se\/investors\/corporate-governance\/management\/","title":{"rendered":"F\u00f6rvaltning"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;88f366a5-bf49-48d9-a338-ab22706b73e7&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_padding_tablet=&#8221;10px||||false|false&#8221; custom_padding_phone=&#8221;0px||||false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][dipi_breadcrumbs _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;800px&#8221; global_module=&#8221;5132&#8243; global_colors_info=&#8221;{}&#8221;][\/dipi_breadcrumbs][et_pb_divider color=&#8221;#EEEEEE&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;800px&#8221; min_height=&#8221;1px&#8221; height=&#8221;20px&#8221; custom_margin=&#8221;||3px|||&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;8738c908-7375-4c6c-99a7-9f91f8a3c099&#8243; header_font_size=&#8221;56px&#8221; max_width=&#8221;800px&#8221; custom_margin=&#8221;||17px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Management<\/h6>\n<h1>IDL Diagnostics AB<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; module_id=&#8221;board&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;e9afc0e7-c9bf-4a12-be49-63ddba231101&#8243; border_width_bottom=&#8221;0px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Management<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/12\/anders_hultman.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Chief Executive Officer (CEO)<\/h6>\n<h6><span>Since 2021<\/span><\/h6>\n<p><span><\/span><\/p>\n<h3>Anders Hultman<\/h3>\n<p>Anders Hultman started his employment at AroCell in 2018. He has more than 20 years of experience in managerial and executive positions in finance, sales, and marketing. Furthermore, he has extensive international experience from several executive positions such as CFO, Sales Director, Product Marketing Director, and CEO in pharma, IT, telecom, and e-commerce companies. Anders has a BSc(Econ) degree.<\/p>\n<p><strong>Holdings in IDL Diagnostics: 1,120,000 shares and 566,000 warrants.<\/strong><\/p>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/11\/Unknown-scaled-e1669035075305.jpeg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Chief Financial Officer (CFO)<\/h6>\n<h6><span>Since 2022<\/span><span><\/span><\/h6>\n<p><span><\/span><\/p>\n<h3>Ellen Dittberner<\/h3>\n<p>Ellen has extensive experience in several different areas such as Group Accounting, Controlling, and Change Management. Ellen has previously worked as Head of Group Accounting at Holmgrens Bil AB. Ellen has an MBA degree.<\/p>\n<p><strong>Holdings in IDL Diagnostics: 566,000 warrants.<\/strong><\/p>\n<p>[\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2025\/02\/Bild-Leyla-289&#215;300-1.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Chief Scientific Officer (CScO)<\/h6>\n<h6><span>Since 2025<\/span><\/h6>\n<p><span><\/span><\/p>\n<h3>Leyla Ali Dholey<\/h3>\n<p><span lang=\"EN-US\" class=\"ContentPasted0\">Leyla has a broad background in life science and developing diagnostic products. She has previously worked at Boule Medical, iCellate Medical, Cepheid, and co-founded Ovulai where she served as CSO, CMO, and board member. Leyla holds an MSc in Engineering Biotechnology.<\/span><\/p>\n<p><strong>Holdings in IDL Diagnostics: null<\/strong><\/p>\n<ul><\/ul>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/05\/Gustav-Steen.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Chief Marketing Officer (CMO)<\/h6>\n<h6><span>Since 2024<\/span><\/h6>\n<p><span><\/span><\/p>\n<h3>Gustav Sten<\/h3>\n<p>Gustav Sten has considerable experience within the development, production, and quality control of diagnostic products. Gustav joined IDL in 2018. He was previously employed at Thermo Fisher Scientific and Fiomi AB. Gustav has a BSc(Eng) degree.<\/p>\n<p><strong>Holdings in IDL Diagnostics: 84,000 shares and 566,000 warrants.<\/strong><\/p>\n<ul><\/ul>\n<p>[\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2024\/11\/1729234571978.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Chief Quality and Regulatory Officer (CQRO)<\/h6>\n<h6><span>Since 2024<\/span><\/h6>\n<p><span><\/span><\/p>\n<h3><span>Jocelyn \u00c5kerberg <\/span><\/h3>\n<div>\n<p>Jocelyn has over 24 years of experience in life science, with 5 years in the pharmaceutical industry and 19 years in medical devices. She has served as a Lead Auditor for Quality Management System and Technical\/Special Audits at the British Standard Institute, and as a Technical Auditor and Technical Product Reviewer at T\u00dcV- S\u00dcD Product Services GmbH.<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<p><strong>Holdings in IDL Diagnostics: null.<\/strong><\/p>\n<ul><\/ul>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2024\/11\/HJEA5432-scaled.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Chief Operations Officer (COO)<\/h6>\n<h6><span>Since 2024<\/span><\/h6>\n<p><span><\/span><\/p>\n<h3><span>Maria Sundberg<\/span><\/h3>\n<p>Maria has worked in the production and quality control of diagnostic products since 2014. She joined IDL in 2020 and was previously employed at QIAGEN DNA Synthesis AB. Maria holds an MSc in Protein Science.<\/p>\n<p><strong>Holdings in IDL Diagnostics: null.<\/strong><\/p>\n<p>[\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2025\/09\/Linkedin-Pic-Xia-002.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Director of Global Market Development<\/h6>\n<h6><span>Since 2025<\/span><\/h6>\n<p><span><\/span><\/p>\n<h3><span>Xia Jiang<\/span><\/h3>\n<div>\n<p><span data-teams=\"true\">Xia has \u00a017 years of experience in the IVD and medical device industry, with a strong track record in managing distribution channels and expanding markets across Asia-Pacific, Europe, and Africa. She has held several business development roles at Actim (Medix Biochemica Group), Aidian, and Optomed Oy in Finland and China, gaining deep expertise in global commercialization and strategic partnerships. Xia holds a MSc in Financial Management and\u00a0 Accounting and a BBA in Business Administration.<\/span><\/p>\n<p><span style=\"font-size: 18px;\">\u00a0<\/span><\/p>\n<\/div>\n<p><strong>Holdings in IDL Diagnostics: null.<\/strong><\/p>\n<ul><\/ul>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Scientific Advisor<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2025\/03\/Stig-Linder.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Scientific Advisor<\/h6>\n<p>&nbsp;<\/p>\n<h3><span>Stig Linder<\/span><\/h3>\n<p>Stig Linder has been a scientific advisor at AroCell since 2022. He studied medicine and received his PhD at the Karolinska Institute and did postdoctoral work at Yale University. Stig is now a senior professor at Karolinska Institute and at Link\u00f6ping University. He has been deputy chairman at the Department of Oncology-Pathology, Karolinska Institute. During his academic career, Stig has supervised or co-supervised approx. 30 PhD students to dissertation. \u00a0Stig has previously had an active role in a Swedish start-up diagnostic company (Peviva AB, now VLVBio AB).<\/p>\n<p><strong>Holdings in IDL Diagnostics: null.<\/strong><\/p>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;3466&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;29&#8243; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][et_pb_sidebar area=&#8221;et_pb_widget_area_2&#8243; disabled_on=&#8221;off|off|on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74&#8243; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;||||false|false&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2177&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2000px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#21242A&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>About us<\/h6>\n<h3>We provide knowledge to decision.<\/h3>\n<p>IDL Diagnosticsis a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/about-arocell\/&#8221; button_text=&#8221;Read more about us&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/MG_7941-800.jpg&#8221; title_text=&#8221;MG_7941-600&#8243; src_tablet=&#8221;&#8221; src_phone=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2023\/08\/MG_7941-600.jpg&#8221; src_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2428&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2000px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;ds-vertical-align&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Bacteriology<\/h6>\n<h3>An effective typhoid test<\/h3>\n<p>Typhoid fever is water and food-borne infectious disease caused by the bacterium, <em>Salmonella<\/em> enterica. IDL Biotechs product TUBEX\u00ae TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/products\/bacteriology\/&#8221; button_text=&#8221;Read more about bacteriology&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;5e8c1032-9074-49bb-92a6-99c20ecc3d02&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-water.jpeg&#8221; title_text=&#8221;Water is Life for African Children, Little Gorgeous Black Girl Drinking from Tap&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><div class=\"et_pb_module dipi_breadcrumbs dipi_breadcrumbs_0\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<div class=\"et_pb_module_inner\">\n\t\t\t\t\t<div class=\"dipi-breadcrumbs dipi-bc-left\">\n                <ul >\n                    \n                                                        <li  class=\"dipi-breadcrumb-item dipi-breadcrumb-home\">\n\n                                                    <a  href=\"https:\/\/idldiagnostics.com\/se\">\n                                <span  content=\"Home\">\n                                                                        IDL Diagnostics                                <\/span>\n                            <\/a>\n\n                                                <meta itemprop=\"position\" content=\"1\"\/>                    <\/li>\n\n                    <li class=\"dipi-breadcrumb-separator\">\n                    <span class=\"et-pb-icon dipi-separator-icon\">&#x35;<\/span>\n                <\/li>                            \n                <\/ul>\n            <\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>Management IDL Diagnostics ABManagementChief Executive Officer (CEO) Since 2021 Anders Hultman Anders Hultman started his employment at AroCell in 2018. He has more than 20 years of experience in managerial and executive positions in finance, sales, and marketing. Furthermore, he has extensive international experience from several executive positions such as [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2253,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<!-- wp:divi\/placeholder \/-->","_et_gb_content_width":"","footnotes":""},"dipi_cpt_category":[],"class_list":["post-2822","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Management - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/investors\/corporate-governance\/management\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Management - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"Management IDL Diagnostics ABManagementChief Executive Officer (CEO) Since 2021 Anders Hultman Anders Hultman started his employment at AroCell in 2018. He has more than 20 years of experience in managerial and executive positions in finance, sales, and marketing. Furthermore, he has extensive international experience from several executive positions such as [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/investors\/corporate-governance\/management\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-03T08:55:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/corporate-governance\\\/management\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/corporate-governance\\\/management\\\/\",\"name\":\"Management - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"datePublished\":\"2021-11-30T09:00:00+00:00\",\"dateModified\":\"2025-10-03T08:55:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/corporate-governance\\\/management\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/corporate-governance\\\/management\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/corporate-governance\\\/management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Corporate Governance\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/corporate-governance\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Management - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/investors\/corporate-governance\/management\/","og_locale":"sv_SE","og_type":"article","og_title":"Management - IDL Diagnostics","og_description":"Management IDL Diagnostics ABManagementChief Executive Officer (CEO) Since 2021 Anders Hultman Anders Hultman started his employment at AroCell in 2018. He has more than 20 years of experience in managerial and executive positions in finance, sales, and marketing. Furthermore, he has extensive international experience from several executive positions such as [&hellip;]","og_url":"https:\/\/idldiagnostics.com\/se\/investors\/corporate-governance\/management\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_modified_time":"2025-10-03T08:55:18+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"9 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/investors\/corporate-governance\/management\/","url":"https:\/\/idldiagnostics.com\/investors\/corporate-governance\/management\/","name":"Management - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"datePublished":"2021-11-30T09:00:00+00:00","dateModified":"2025-10-03T08:55:18+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/investors\/corporate-governance\/management\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/investors\/corporate-governance\/management\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/investors\/corporate-governance\/management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"Investors","item":"https:\/\/idldiagnostics.com\/investors\/"},{"@type":"ListItem","position":3,"name":"Corporate Governance","item":"https:\/\/idldiagnostics.com\/investors\/corporate-governance\/"},{"@type":"ListItem","position":4,"name":"Management"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=2822"}],"version-history":[{"count":18,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2822\/revisions"}],"predecessor-version":[{"id":5338,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2822\/revisions\/5338"}],"up":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2253"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=2822"}],"wp:term":[{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=2822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}